GACIX
Price
$55.18
Change
-$0.57 (-1.02%)
Updated
Aug 10 closing price
Net Assets
1.92B
VSCIX
Price
$146.17
Change
-$0.48 (-0.33%)
Updated
Aug 10 closing price
Net Assets
183.38B
Interact to see
Advertisement

GACIX vs VSCIX

GACIX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
GACIX vs. VSCIX commentary
Aug 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GACIX is a Hold and VSCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 183B vs. GACIX (1.92B). VSCIX pays higher dividends than GACIX: VSCIX (1.23) vs GACIX (0.43). GACIX was incepted earlier than VSCIX: GACIX (19 years) vs VSCIX (29 years). GACIX (1.13) is less costly to investors than VSCIX (0.03). VSCIX is a more actively managed with annual turnover of: 17.00 vs. GACIX (1.00). GACIX has a lower initial minimum investment than VSCIX: GACIX (50000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 27.86 vs. GACIX (19.95). VSCIX return over 5 years is better than : 38.65 vs. GACIX (6.13).
GACIXVSCIXGACIX / VSCIX
Total Expense Ratio1.130.033,767%
Annual Report Gross Expense Ratio1.130.033,767%
Fund Existence19 years29 years-
Gain YTD17.93918.86295%
Front LoadN/AN/A-
Min. Initial Investment5000050000001%
Min. Initial Investment IRAN/AN/A-
Net Assets1.92B183B1%
Annual Yield % from dividends0.431.2335%
Returns for 1 year19.9527.8672%
Returns for 3 years23.8153.2345%
Returns for 5 years6.1338.6516%
Returns for 10 years12.59161.208%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBOX74.67N/A
N/A
Rydex Biotechnology A
MCLRX18.39N/A
N/A
BlackRock Advantage Large Cap Core Inv C
PABGX208.80N/A
N/A
T. Rowe Price Blue Chip Growth Advisor
HSCCX3.26N/A
N/A
Carillon Eagle Small Cap Growth C
WSMNX28.54N/A
N/A
William Blair Small-Mid Cap Growth N